Member access

4-Traders Homepage  >  Shares  >  Mercado Continuo Espanol  >  Grifols SA    GRF   ES0171996012

GRIFOLS SA (GRF)

56
Delayed Quote. Delayed BATS Europe - 03/06 11:29:59 am
36.685 EUR   +0.04%
03/04 GRIFOLS : to make a major equity investment in Alkahest Download (38..
03/02DJNovartis, GlaxoSmithKline Complete Series of Deals - Update
03/02DJNovartis, GlaxoSmithKline Complete Deals
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mercado Continuo Espanol
03/02/2015 03/03/2015 03/04/2015 03/05/2015 03/06/2015 Date
35.8(c) 35.185(c) 35.775(c) 36.67(c) 36.76(c) Last
1 141 669 699 535 4 110 360 894 635 583 549 Volume
-1.25% -1.72% +1.68% +2.50% +0.25% Change
More quotes
Company
Grifols SA is a vertically integrated global producer of plasma derivatives.Its activities include sourcing raw material, manufacturing various plasma derivative products and selling and distributing final products to healthcare providers.The company operates through four segments: Bioessence,... 
Sector
Pharmaceuticals
Calendar
05/05Earnings Release
More about the company
Surperformance© ratings of Grifols SA
Trading Rating : Investor Rating :
More Ratings
Chart GRIFOLS SA
Duration : Period :
Grifols SA Technical Analysis Chart | GRF | ES0171996012 | 4-Traders
Full-screen chart
Financials (€)
Sales 2015 3 711 M
EBIT 2015 950 M
Net income 2015 534 M
Debt 2015 2 951 M
Yield 2015 1,79%
Sales 2016 3 990 M
EBIT 2016 1 023 M
Net income 2016 609 M
Debt 2016 2 786 M
Yield 2016 2,07%
PER 2015 21,75
PER 2016 19,03
EV / Sales 2015 3,95x
EV / Sales 2016 3,63x
Capitalization 11 713 M
More Financials
Latest news on GRIFOLS SA
03/04 GRIFOLS : to make a major equity investment in Alkahest Download (380.5 Kb)
03/02DJNovartis, GlaxoSmithKline Complete Series of Deals - Update
03/02DJNovartis, GlaxoSmithKline Complete Deals
03/02DJNovartis, GlaxoSmithKline Complete Series of Deals
02/26 GRIFOLS : achieves a record net profit of 470.3 million euros with growth of 36...
02/19 GRIFOLS : PhocusRx Certified DIACAP Compliant
01/08 GRIFOLS : new immunoglobulin purification plant in the United States receives FD..
01/05 GRIFOLS : receives FDA approval for its new purification plant to produce Gamune..
More news
Sector news Biopharmaceuticals
05:34pDJBristol-Myers Squibb Sets Pay for Incoming, Retiring CEOs
04:10p AKORN : Federman & Sherwood : Announces Filing of Securities Class Action Lawsui..
03:57p ASTELLAS PHARMA : FDA approves Astellas drug for serious fungal infections
Plus d'actualités du secteur Biopharmaceuticals


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF